StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Regenerative Medical Technology's free cash flow for the twelve months ending Jun 30, 2026 was -$582.33K. For fiscal 2025 it was -$1.31M, down 306.1% from the year before. The highest annual figure on record is $635.28K in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.31M-306.1%
FY2024Dec 31, 2024$635.28K–
FY2023Dec 31, 2023-$804.80K–
FY2022Dec 31, 2022-$1.31M–
FY2020Dec 31, 2020-$422.75K–
FY2019Dec 31, 2019-$462.33K–
FY2018Dec 31, 2018-$248.64K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$288.48K-12.4%
Q1 FY2026Mar 31, 2026-$213.27K-197.2%
Q4 FY2025Dec 31, 2025-$228.98K-706.7%
Q3 FY2025Sep 30, 2025-$428.56K-978.0%
Q4 FY2024Dec 31, 2024$329.39K–
Q3 FY2024Sep 30, 2024$219.33K–
Q2 FY2024Jun 30, 2024$37.74K–
Q1 FY2024Mar 31, 2024$48.81K+3686.8%
Q4 FY2023Dec 31, 2023-$313.40K–
Q3 FY2023Sep 30, 2023-$81.25K–
Q2 FY2023Jun 30, 2023-$411.43K–
Q1 FY2023Mar 31, 2023$1.29K–
Q4 FY2022Dec 31, 2022-$117.96K–
Q3 FY2022Sep 30, 2022-$153.44K–
Q1 FY2021Mar 31, 2021-$254.86K–
Q4 FY2020Dec 31, 2020-$96.94K–
Q3 FY2020Sep 30, 2020-$92.10K–
Q2 FY2020Jun 30, 2020-$69.03K–
Q1 FY2020Mar 31, 2020-$164.68K–
Q4 FY2019Dec 31, 2019-$48.45K–
Q3 FY2019Sep 30, 2019-$134.68K–
Q2 FY2019Jun 30, 2019-$86.57K–
Q1 FY2019Mar 31, 2019-$192.63K–
Q4 FY2018Dec 31, 2018-$73.87K–

More Regenerative Medical Technology figures

See a number that looks wrong?